Lavrisha, Lisa, Heyn, NP

Youn H. Kim, M.D., is a Professor of Dermatology and member of the Stanford Cancer Institute. She is the Director of Stanford's Multidisciplinary Cutaneous Lymphoma Clinic/Program (MCLP). Her current research is dedicated towards strengthening the collaborative interface for novel discoveries and exploring new and improved therapies with tumor-specific targets and enhanced synergy and/or potency. She and her multidisciplinary colleagues are exploring novel immune/cell therapy modalities including in situ vaccination, immune checkpoint blockades, and unique allogeneic HSCT strategies.

Dr. Gabriel Mannis is Associate Professor of Medicine in the Division of Hematology at Stanford University School of Medicine, and Medical Director of Stanfords Inpatient Leukemia Service. He specializes in the treatment of acute myeloid leukemia (AML), high-risk myelodysplastic syndromes (MDS), and other hematologic malignancies. As a clinical scientist, Dr. Mannis divides his time between caring for patients, teaching trainees, and researching novel therapies for AML and MDS. Dr. Mannis has co-authored numerous publications on topics including AML, hematopoietic cell transplantation, and advanced care planning for patients with hematologic malignancies. Currently, Dr.

Dr. Thong is a surgeon specializing in urologic oncology. He has expertise in all aspects of prostate, kidney, bladder, and testicular cancer care, including endoscopic, robotic, and open surgery, and has a special interest in complex cases including: salvage surgery following radiation or chemotherapy, resection of locally advanced tumors, minimal access robotic surgery, and MRI-US fusion targeted biopsies. Dr. Thong is the first surgeon in northern California to utilize single port robotic assisted laparoscopic technology for both pelvic and retroperitoneal surgeries. He has won numerous awards including the NIH Ruth L.